Journals / Turkish Journal of Pediatrics / 1999 / Cilt: 41 - Sayı: 1

Intermittent chemotherapy for miliary tuberculosis in children

Pages
53–59
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intermittent therapy is safe and effective in miliary tuberculosis and it may be an alternative therapy because of its minimal toxicity and lower cost.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Miliary tuberculosis is a severe manifestation of tuberculosis.
📊
Key Findings & Data:Six children aged between two months and 10 years with the diagnosis of miliary tuberculosis were treated with intermittent antituberculous therapy for six, nine or 12 months.
💡
Conclusion & Impact:Intermittent therapy is safe and effective in miliary tuberculosis and it may be an alternative therapy because of its minimal toxicity and lower cost.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Miliary tuberculosis is a severe manifestation of tuberculosis. Six children aged between two months and 10 years with the diagnosis of miliary tuberculosis were treated with intermittent antituberculous therapy for six, nine or 12 months. All the patients showed clearance of both clinical and radiological symptoms; there was no drug toxicity or resistance and no relapses were seen in the follow-up period ranging from nine months to nine years. Intermittent therapy is safe and effective in miliary tuberculosis and it may be an alternative therapy because of its minimal toxicity and lower cost.

🔖

Cite This Article

ANADOL, D., KİPER, N., GÖÇMEN, A., ÖZÇELİK, U. (2022). Intermittent chemotherapy for miliary tuberculosis in children. Turkish Journal of Pediatrics, Cilt: 41 - Sayı: 1, 53–59. https://ajindex.com/articles/613448

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...